AXL Inhibitors Promote Anti-Tumor Immunity through Modulation of Macrophage Polarization. Shenshen Lai, Qin Xu, Jun Yan, Hong Zhang, Zaihui Zhang. Abstract No. 3853 presented at 2018 AACR Annual Meeting, Chicago, IL. Click to View Poster
Activity of the TAM kinase-targeting compound, SLC-391, is mediated by the engagement of the immune system in CT-26 syngeneic mouse model. Shenshen Lai, Rick Li, Paromita Raha, Yuxiang Hu, Jun Yan, Hong Zhang, Anthony Marotta, Zaihui Zhang. Abstract No. B148, presented at 2018 AACR Annual Meeting, Chicago, IL. Click to View Poster
Anti-Tumor Activity of a TAM Kinase-targeting Compound in CT-26 Syngeneic Mouse Model. Shenshen Lai, Rick Li, Paromita Raha, Yuxiang Hu, Zaihui Zhang, Jun Yan, Hong Zhang. Abstract No. 4196, presented at 2017 AACR Annual Meeting, Washington DC. Click to View Poster
Evaluation of Compounds Developed against AXL Kinase. Zaihui Zhang, Hong Zhang, Xiaoqing Shi, Erica Lee, Rick Li, Yuxiang Hu, Jun Yan, Jasbinder Sanghera. Abstract No. 5393, presented at 2015 AACR Annual Meeting, Philadelphia, PA. Click to View Poster
Discovery of Novel TAM Family Kinase Inhibitors. Zaihui Zhang, Hong Zhang, Rick Li, Erica Lee, Xiaoqing Shi, Yuxiang Hu, Jun Yan, Jasbinder Sanghera. Abstract No. 2716, presented at 2014 AACR Annual Meeting, San Diego, CA. Click to View Poster
Novel and Selective Axl Inhibitors. Zaihui Zhang, Hong Zhang, Rick Li, Erica Lee, Xiaoqing Shi, Yuxiang Hu, Jun Yan, Jasbinder Sanghera. Abstract No. 1746, presented at 2014 AACR Annual Meeting, San Diego, CA. Click to View Poster
